Marta Kwiatkowska
Marta Kwiatkowska has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Małgorzata Landowska
Department of Internal Medicine, Endocrinology and Diabetology, National Medical Institute of the Ministry of the Interior and Administration in Warsaw, 02-507 Warsaw, Poland
4 shared publications - Nina Kubikowska
Medical University of Warsaw, Warsaw, Poland
4 shared publications - Iga Poprawa
Medical University of Warsaw, Warsaw, Poland
3 shared publications - Patryk Krawczak3 shared publications
- Przemysław Krukowski3 shared publications
- Zuzanna Gąsior3 shared publications
Latest Publications
- 30 April 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (2)
NIGHT AND SHIFT WORK – A REVIEW OF THE IMPACT ON PHYSICAL AND MENTAL HEALTH
Background Shift and night work are essential for the functioning of modern societies but are associated with significant disruption of the circadian rhythm. This disruption has been linked to a wide range of adverse health outcomes affecting mental, physical, and endocrine function. Despite growing evidence, the multidomain consequences of shift work remain insufficiently recognized in clinical and occupational practice, and no integrative synthesis has yet examined these effects with particular emphasis on healthcare professionals. Aims This review aimed to provide a comprehensive and updated synthesis of the adverse health effects of night and shift work, to identify specific risk domains, and to summarize evidence-based preventive strategies applicable in occupational settings. Methods A narrative review of the literature was conducted using PubMed, Google Scholar, and ResearchGate. Publications from 2010 to 2026 were included. Eligible study types comprised meta-analyses, systematic reviews, cohort studies, and case-control studies reporting on health outcomes associated with night or shift work schedules. Results Shift workers demonstrate significantly higher rates of depression, anxiety, suicidal ideation, and cognitive decline. Approximately 30% develop shift work disorder. Cardiometabolic consequences include hypertension, cardiovascular events, obesity, dyslipidemia, type 2 diabetes, and metabolic syndrome. Endocrine disruptions affect melatonin, cortisol, thyroid, and sex hormones, contributing to menstrual irregularities, earlier menopause, and increased miscarriage risk. Conclusions Shift work exerts substantial multidomain negative effects on health. Targeted preventive interventions, including light therapy, structured sleep and meal schedules, and psychological support, are warranted, particularly in healthcare professionals and other vulnerable populations.
- 30 April 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (2)
NIGHT AND SHIFT WORK – A REVIEW OF THE IMPACT ON PHYSICAL AND MENTAL HEALTH
Background Shift and night work are essential for the functioning of modern societies but are associated with significant disruption of the circadian rhythm. This disruption has been linked to a wide range of adverse health outcomes affecting mental, physical, and endocrine function. Despite growing evidence, the multidomain consequences of shift work remain insufficiently recognized in clinical and occupational practice, and no integrative synthesis has yet examined these effects with particular emphasis on healthcare professionals. Aims This review aimed to provide a comprehensive and updated synthesis of the adverse health effects of night and shift work, to identify specific risk domains, and to summarize evidence-based preventive strategies applicable in occupational settings. Methods A narrative review of the literature was conducted using PubMed, Google Scholar, and ResearchGate. Publications from 2010 to 2026 were included. Eligible study types comprised meta-analyses, systematic reviews, cohort studies, and case-control studies reporting on health outcomes associated with night or shift work schedules. Results Shift workers demonstrate significantly higher rates of depression, anxiety, suicidal ideation, and cognitive decline. Approximately 30% develop shift work disorder. Cardiometabolic consequences include hypertension, cardiovascular events, obesity, dyslipidemia, type 2 diabetes, and metabolic syndrome. Endocrine disruptions affect melatonin, cortisol, thyroid, and sex hormones, contributing to menstrual irregularities, earlier menopause, and increased miscarriage risk. Conclusions Shift work exerts substantial multidomain negative effects on health. Targeted preventive interventions, including light therapy, structured sleep and meal schedules, and psychological support, are warranted, particularly in healthcare professionals and other vulnerable populations.
- 28 February 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (1)
Gel Manicure and Associated Risks - narrative review
Background Gel manicure is widely used in professional and home settings. Concerns relate to chemical exposure from acrylate containing nail products, ultraviolet radiation emitted by nail curing lamps, occupational exposure among nail technicians, and potential microbiological implications. Aims To systematize published evidence on health effects associated with gel manicure use, with emphasis on allergic reactions, ultraviolet exposure related outcomes, occupational risks, and microbiological findings, and to identify gaps in the current evidence base. Methods A narrative review was conducted using PubMed, Google Scholar, and ResearchGate. Publications from January 2010 to March 2025 were considered. Only English language articles were included. Inclusion criteria comprised randomized controlled trials, cohort studies, case control studies, systematic reviews, meta analyses, and international or national guidelines reporting health effects or exposure characteristics related to gel manicure use. Exclusion criteria included single case reports, conference abstracts, non peer reviewed publications, animal studies, and articles lacking explicit data on gel manicure exposure or associated health outcomes. The initial search yielded 223 records, and 44 publications were retained for analysis. Results Nail curing devices predominantly emit UVA radiation with peak wavelengths between 365 and 405 nm, with substantial variability across lamp types and designs. Under typical usage conditions, cumulative ultraviolet exposure during manicure sessions remains below levels associated with clinically significant dermatologic damage or increased skin cancer risk. Allergic contact dermatitis related to acrylate and methacrylate containing products is the most frequently reported adverse outcome, particularly among nail technicians and younger users. Evidence on microbial retention and reduced hand hygiene effectiveness with gel or artificial nails is heterogeneous and context dependent. Conclusions Available evidence indicates that allergic sensitization to acrylate containing nail products represents the primary clinically relevant health risk of gel manicure, whereas ultraviolet radiation related carcinogenic risk appears minimal under typical use. Standardization of exposure assessment and further research on occupational and microbiological outcomes are needed.
- 28 February 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (1)
Gel Manicure and Associated Risks - narrative review
Background Gel manicure is widely used in professional and home settings. Concerns relate to chemical exposure from acrylate containing nail products, ultraviolet radiation emitted by nail curing lamps, occupational exposure among nail technicians, and potential microbiological implications. Aims To systematize published evidence on health effects associated with gel manicure use, with emphasis on allergic reactions, ultraviolet exposure related outcomes, occupational risks, and microbiological findings, and to identify gaps in the current evidence base. Methods A narrative review was conducted using PubMed, Google Scholar, and ResearchGate. Publications from January 2010 to March 2025 were considered. Only English language articles were included. Inclusion criteria comprised randomized controlled trials, cohort studies, case control studies, systematic reviews, meta analyses, and international or national guidelines reporting health effects or exposure characteristics related to gel manicure use. Exclusion criteria included single case reports, conference abstracts, non peer reviewed publications, animal studies, and articles lacking explicit data on gel manicure exposure or associated health outcomes. The initial search yielded 223 records, and 44 publications were retained for analysis. Results Nail curing devices predominantly emit UVA radiation with peak wavelengths between 365 and 405 nm, with substantial variability across lamp types and designs. Under typical usage conditions, cumulative ultraviolet exposure during manicure sessions remains below levels associated with clinically significant dermatologic damage or increased skin cancer risk. Allergic contact dermatitis related to acrylate and methacrylate containing products is the most frequently reported adverse outcome, particularly among nail technicians and younger users. Evidence on microbial retention and reduced hand hygiene effectiveness with gel or artificial nails is heterogeneous and context dependent. Conclusions Available evidence indicates that allergic sensitization to acrylate containing nail products represents the primary clinically relevant health risk of gel manicure, whereas ultraviolet radiation related carcinogenic risk appears minimal under typical use. Standardization of exposure assessment and further research on occupational and microbiological outcomes are needed.
- 28 February 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (1)
The Role of Semaglutide in Obesity Treatment: Effectiveness and Safety Based on Current Evidence
Background Obesity is a chronic disease associated with increased cardiometabolic risk and requires long term multidisciplinary management. Semaglutide, a glucagon like peptide 1 receptor agonist, has emerged as an effective pharmacological option for weight management. The aim of this narrative review is to analyze current clinical evidence on the efficacy, safety, and adverse event profile of semaglutide in adults with overweight or obesity. Methods A narrative review of publications indexed in PubMed, Scopus, Web of Science, Embase, Google Scholar, and ResearchGate was conducted. Eligible studies published between 2020 and 2026 included randomized controlled trials, cohort studies, systematic reviews, meta analyses, and international clinical guidelines. Only studies involving adult participants meeting established indications for pharmacological obesity treatment, defined as a body mass index of at least 30 kg per square meter or at least 27 kg per square meter with weight related comorbidities, were included. Results The review synthesizes evidence from the STEP 1 to 8 clinical trials evaluating once weekly subcutaneous semaglutide in diverse clinical and ethnic populations. Across all trials, semaglutide in combination with lifestyle modification was consistently associated with clinically meaningful weight reduction compared with placebo. Comparative data demonstrate greater weight loss with semaglutide than with liraglutide in adults without diabetes mellitus. Semaglutide was effective in Asian populations characterized by increased cardiometabolic risk at lower body mass index values and was associated with reductions in visceral adipose tissue. In individuals with type 2 diabetes mellitus, weight loss was less pronounced but remained clinically relevant. The most frequently reported adverse events were gastrointestinal in nature and were predominantly mild to moderate in severity, with low rates of serious adverse events and treatment discontinuation. Conclusions Current clinical evidence indicates that once weekly subcutaneous semaglutide, used as an adjunct to lifestyle intervention, is an effective and generally well tolerated pharmacological option for weight management in adults with overweight or obesity. Maintenance of weight reduction requires continued treatment, supporting the concept of obesity as a chronic condition requiring long term therapeutic strategies.
- 28 February 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (1)
The Role of Semaglutide in Obesity Treatment: Effectiveness and Safety Based on Current Evidence
Background Obesity is a chronic disease associated with increased cardiometabolic risk and requires long term multidisciplinary management. Semaglutide, a glucagon like peptide 1 receptor agonist, has emerged as an effective pharmacological option for weight management. The aim of this narrative review is to analyze current clinical evidence on the efficacy, safety, and adverse event profile of semaglutide in adults with overweight or obesity. Methods A narrative review of publications indexed in PubMed, Scopus, Web of Science, Embase, Google Scholar, and ResearchGate was conducted. Eligible studies published between 2020 and 2026 included randomized controlled trials, cohort studies, systematic reviews, meta analyses, and international clinical guidelines. Only studies involving adult participants meeting established indications for pharmacological obesity treatment, defined as a body mass index of at least 30 kg per square meter or at least 27 kg per square meter with weight related comorbidities, were included. Results The review synthesizes evidence from the STEP 1 to 8 clinical trials evaluating once weekly subcutaneous semaglutide in diverse clinical and ethnic populations. Across all trials, semaglutide in combination with lifestyle modification was consistently associated with clinically meaningful weight reduction compared with placebo. Comparative data demonstrate greater weight loss with semaglutide than with liraglutide in adults without diabetes mellitus. Semaglutide was effective in Asian populations characterized by increased cardiometabolic risk at lower body mass index values and was associated with reductions in visceral adipose tissue. In individuals with type 2 diabetes mellitus, weight loss was less pronounced but remained clinically relevant. The most frequently reported adverse events were gastrointestinal in nature and were predominantly mild to moderate in severity, with low rates of serious adverse events and treatment discontinuation. Conclusions Current clinical evidence indicates that once weekly subcutaneous semaglutide, used as an adjunct to lifestyle intervention, is an effective and generally well tolerated pharmacological option for weight management in adults with overweight or obesity. Maintenance of weight reduction requires continued treatment, supporting the concept of obesity as a chronic condition requiring long term therapeutic strategies.
- 30 October 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (5)
The impact of lifestyle modifications on polycystic ovary syndrome phenotypes: a narrative review
Background and Aim: Polycystic Ovary Syndrome (PCOS) affects 5–16% of women of reproductive age and is associated with significant reproductive, metabolic, and psychological consequences. Lifestyle modification, including diet and physical activity, is universally recommended as first-line therapy. However, most clinical studies and guidelines treat PCOS as a homogeneous condition, overlooking the heterogeneity defined by the Rotterdam phenotypes. This reduces the applicability of current recommendations. The novelty of this review lies in focusing on phenotype-specific responses to lifestyle interventions. The aim is to summarize available evidence on dietary approaches, physical activity, supplementation, and behavioral factors across PCOS phenotypes and to identify gaps for future research. Methods: A narrative review was performed using PubMed, Google Scholar, and ResearchGate. Eligible publications included randomized controlled trials, systematic reviews, meta-analyses, and international guidelines published after 2018. Search terms combined PCOS, phenotype, diet, physical activity, insulin resistance, hyperandrogenism, supplementation, smoking, and sleep. Results: Evidence indicates that aerobic exercise, high-intensity interval training, low-AGE and high-fiber hypocaloric diets, and selected supplements such as β-hydroxybutyrate and N-acetylcysteine improve metabolic and hormonal outcomes. These effects are most pronounced in classical phenotypes A and B, characterized by hyperandrogenism and insulin resistance. Non-hyperandrogenic phenotypes, such as D, show limited response to interventions targeting androgen excess. Behavioral factors, including smoking and sleep disturbances, aggravate metabolic dysfunctions and worsen outcomes in hyperandrogenic phenotypes. Conclusions: Lifestyle modification remains central to PCOS management, but its effectiveness is not uniform across phenotypes. Tailoring dietary, exercise, and adjunctive strategies to the endocrine and metabolic characteristics of each phenotype may improve outcomes. Future research should prioritize phenotype-stratified trials to provide evidence-based recommendations that reflect the heterogeneity of PCOS.
- 30 October 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (5)
The impact of lifestyle modifications on polycystic ovary syndrome phenotypes: a narrative review
Background and Aim: Polycystic Ovary Syndrome (PCOS) affects 5–16% of women of reproductive age and is associated with significant reproductive, metabolic, and psychological consequences. Lifestyle modification, including diet and physical activity, is universally recommended as first-line therapy. However, most clinical studies and guidelines treat PCOS as a homogeneous condition, overlooking the heterogeneity defined by the Rotterdam phenotypes. This reduces the applicability of current recommendations. The novelty of this review lies in focusing on phenotype-specific responses to lifestyle interventions. The aim is to summarize available evidence on dietary approaches, physical activity, supplementation, and behavioral factors across PCOS phenotypes and to identify gaps for future research. Methods: A narrative review was performed using PubMed, Google Scholar, and ResearchGate. Eligible publications included randomized controlled trials, systematic reviews, meta-analyses, and international guidelines published after 2018. Search terms combined PCOS, phenotype, diet, physical activity, insulin resistance, hyperandrogenism, supplementation, smoking, and sleep. Results: Evidence indicates that aerobic exercise, high-intensity interval training, low-AGE and high-fiber hypocaloric diets, and selected supplements such as β-hydroxybutyrate and N-acetylcysteine improve metabolic and hormonal outcomes. These effects are most pronounced in classical phenotypes A and B, characterized by hyperandrogenism and insulin resistance. Non-hyperandrogenic phenotypes, such as D, show limited response to interventions targeting androgen excess. Behavioral factors, including smoking and sleep disturbances, aggravate metabolic dysfunctions and worsen outcomes in hyperandrogenic phenotypes. Conclusions: Lifestyle modification remains central to PCOS management, but its effectiveness is not uniform across phenotypes. Tailoring dietary, exercise, and adjunctive strategies to the endocrine and metabolic characteristics of each phenotype may improve outcomes. Future research should prioritize phenotype-stratified trials to provide evidence-based recommendations that reflect the heterogeneity of PCOS.